The anti-cancer functions of DC-based and also T cell-infiltrating lymphocytes (TILs) therapy could be obstructed by downregulation of MHC molecule, and upregulation of immune checkpoint ligand on cancer cells, which are characterized as immune escape mechanisms30,31. Here, HLA-C is linked to cancer.